Skip to content

Bruker BRKR Net Income

Net Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.65B+9.6%
Danaher logo
DanaherDHR
$1.03B+7.9%
TEC
Bio-TechneTECH
$51.05M+126%
WAT
Waters CorporationWAT
-$72M-160%
Agilent Technologies logo
Agilent TechnologiesA
$339M+57.7%
Revvity logo
RevvityRVTY
$40.72M-3.6%

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's net income?
Bruker (BRKR) reported net income of $14.4M in Q1 2026.
How has Bruker's net income changed year-over-year?
Bruker's net income decreased by 17.2% year-over-year, from $17.4M to $14.4M.
What is the long-term trend for Bruker's net income?
Over 3 years (2021 to 2024), Bruker's net income has grown at a -25.8% compound annual growth rate (CAGR), from $277.1M to $113.1M.
What does net income mean?
The final profit or loss remaining after all expenses and taxes are paid.
How do you interpret net income?
Higher net income indicates strong overall profitability and value creation for shareholders.
How does net income compare across companies?
The primary metric for evaluating overall financial health against direct competitors in the scientific instrumentation market.